Clinical trial
Tocladesine in Treating Patients With Recurrent or Progressive Metastatic…
NCT00021268 · Jonsson Comprehensive Cancer Center, Other · Unknown status
Key facts
| NCT number | NCT00021268 |
|---|---|
| Title | Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal Cancer |
| Official title | Phase I Study Of Tocladesine In Patients With Colorectal Carcinoma Following Therapy With 5-FU And Irinotecan |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | tocladesine |
| Start date | Apr 1, 2001 |
| First posted | Sep 10, 2003 |
| Last update posted | Aug 2, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: